138 related articles for article (PubMed ID: 37558157)
1. Risk assessment of the asthma-induction potential of substances in spray products for car cabin detailing - based on EU's Chemical Agents Directive, using harmonised classifications and quantitative structure-activity relationship (QSAR).
Mikkelsen K; Sørli JB; Frederiksen M; Hadrup N
Toxicology; 2023 Aug; 495():153612. PubMed ID: 37558157
[TBL] [Abstract][Full Text] [Related]
2. Asthma-inducing potential of 28 substances in spray cleaning products-Assessed by quantitative structure activity relationship (QSAR) testing and literature review.
Hadrup N; Frederiksen M; Wedebye EB; Nikolov NG; Carøe TK; Sørli JB; Frydendall KB; Liguori B; Sejbaek CS; Wolkoff P; Flachs EM; Schlünssen V; Meyer HW; Clausen PA; Hougaard KS
J Appl Toxicol; 2022 Jan; 42(1):130-153. PubMed ID: 34247391
[TBL] [Abstract][Full Text] [Related]
3. Identification of substances with a carcinogenic potential in spray-formulated engine/brake cleaners and lubricating products, available in the European Union (EU) - based on IARC and EU-harmonised classifications and QSAR predictions.
Sørli JB; Frederiksen M; Nikolov NG; Wedebye EB; Hadrup N
Toxicology; 2022 Jul; 477():153261. PubMed ID: 35863487
[TBL] [Abstract][Full Text] [Related]
4. Insufficient respiratory hazard identification in the safety data sheets for cleaning and disinfection products used in healthcare organisations across England and Wales.
Lee S; Povey AC; Seed MJ; van Tongeren M
Occup Environ Med; 2021 Apr; 78(4):293-295. PubMed ID: 33563606
[TBL] [Abstract][Full Text] [Related]
5. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
6. Thresholds in chemical respiratory sensitisation.
Cochrane SA; Arts JHE; Ehnes C; Hindle S; Hollnagel HM; Poole A; Suto H; Kimber I
Toxicology; 2015 Jul; 333():179-194. PubMed ID: 25963507
[TBL] [Abstract][Full Text] [Related]
7. A scoping survey of attitudes towards occupational exposure limits and REACH derived no effect levels for workers among chemical risk managers at Swedish workplaces.
Schenk L
Int J Occup Med Environ Health; 2020 Sep; 33(5):611-620. PubMed ID: 32699425
[TBL] [Abstract][Full Text] [Related]
8. Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2003; 22 Suppl 3():1-108. PubMed ID: 14617432
[TBL] [Abstract][Full Text] [Related]
9. Classification of chemicals as respiratory allergens based on human data: Requirements and practical considerations.
Pemberton MA; Kimber I
Regul Toxicol Pharmacol; 2021 Jul; 123():104925. PubMed ID: 33831493
[TBL] [Abstract][Full Text] [Related]
10. Occupational and work-related respiratory disease attributed to cleaning products.
Carder M; Seed MJ; Money A; Agius RM; van Tongeren M
Occup Environ Med; 2019 Aug; 76(8):530-536. PubMed ID: 31167951
[TBL] [Abstract][Full Text] [Related]
11. Estimation of the chemical-induced eye injury using a Weight-of-Evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part II: corrosion potential.
Verma RP; Matthews EJ
Regul Toxicol Pharmacol; 2015 Mar; 71(2):331-6. PubMed ID: 25510831
[TBL] [Abstract][Full Text] [Related]
12. A comparison of REACH-derived no-effect levels for workers with EU indicative occupational exposure limit values and national limit values in Finland.
Tynkkynen S; Santonen T; Stockmann-Juvala H
Ann Occup Hyg; 2015 May; 59(4):401-15. PubMed ID: 25638729
[TBL] [Abstract][Full Text] [Related]
13. Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part I: irritation potential.
Verma RP; Matthews EJ
Regul Toxicol Pharmacol; 2015 Mar; 71(2):318-30. PubMed ID: 25497990
[TBL] [Abstract][Full Text] [Related]
14. Does industry take the susceptible subpopulation of asthmatic individuals into consideration when setting derived no-effect levels?
Johansson MK; Johanson G; Öberg M; Schenk L
J Appl Toxicol; 2016 Nov; 36(11):1379-91. PubMed ID: 27283874
[TBL] [Abstract][Full Text] [Related]
15. Interpreting REACH guidance in the determination of the derived no effect level (DNEL).
Kreider ML; Spencer Williams E
Regul Toxicol Pharmacol; 2010 Nov; 58(2):323-9. PubMed ID: 20655351
[TBL] [Abstract][Full Text] [Related]
16. RespiraTox - Development of a QSAR model to predict human respiratory irritants.
Wehr MM; Sarang SS; Rooseboom M; Boogaard PJ; Karwath A; Escher SE
Regul Toxicol Pharmacol; 2022 Feb; 128():105089. PubMed ID: 34861320
[TBL] [Abstract][Full Text] [Related]
17. QSAR Use in REACH Analyses of Alternatives to Predict Human Health and Environmental Toxicity of Alternative Chemical Substances.
Chinen K; Malloy T
Integr Environ Assess Manag; 2020 Sep; 16(5):745-760. PubMed ID: 32162772
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the potential human health risks from exposure to complex substances in accordance with REACH requirements. "White spirit" as a case study.
McKee RH; Tibaldi R; Adenuga MD; Carrillo JC; Margary A
Regul Toxicol Pharmacol; 2018 Feb; 92():439-457. PubMed ID: 29069582
[TBL] [Abstract][Full Text] [Related]
19. A tiered asthma hazard characterization and exposure assessment approach for evaluation of consumer product ingredients.
Maier A; Vincent MJ; Parker A; Gadagbui BK; Jayjock M
Regul Toxicol Pharmacol; 2015 Dec; 73(3):903-13. PubMed ID: 26416168
[TBL] [Abstract][Full Text] [Related]
20. Toluene diisocyanate (TDI) airway effects and dose-responses in different animal models.
Schupp T; Collins MA
EXCLI J; 2012; 11():416-35. PubMed ID: 27298608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
